Products & Services


Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
News Explore

Blog: Resolving structural variants causing antithrombin deficiency

14th September 2020

In this blog, Alba Sanchis-Juan, Javier Corral, and Belén de la Morena-Barrio describe their research into the genetic basis of thrombophilia, and how nanopore long sequencing reads were ...

Read more

Blog: Revealing the impact of structural variants on cancer susceptibility

2nd September 2020

In this blog, Katherine Dixon shares her team’s work on identifying structural variants in cancer genomes, and she explains why identifying them accurately is so important. Katherine ...

Read more

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

3rd August 2020

Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with ...

Read more

First complete assembly of human X chromosome

15th July 2020

The first telomere-to-telomere human chromosome was published in Nature this week — a landmark achievement for genomics researchers. Lead author Karen Miga, from the UC Santa Cruz Genomi...

Read more

Interview: Identification of structural variation in chimpanzees using optical mapping and nanopore sequencing

10th July 2020

Daniela Soto is a Ph.D. candidate in the Integrative Genetics and Genomics program at UC Davis, working in the Dennis Lab where she is using long-read sequencing technologies to unveil ...

Read more

LamPORE for SARS-CoV-2 detection: the science behind the new assay

20th June 2020

LamPORE is a new assay, in advanced development at Oxford Nanopore. It is designed to detect the presence of SARS-CoV-2, the virus that causes COVID-19, in a saliva, swab or environmenta...

Read more

Oxford Nanopore announces pathway to diagnostics and other regulated markets

19th June 2020

Company launches Q Line sequencing portfolio for users in regulated settings Oxford Nanopore today announced its pathway towards providing products for the diagnostics and other regulat...

Read more

London Calling 2020

18th June 2020

London Calling this year took a very different format, going online for the first time ever. With over 5,500 people tuning in to see the action, either live or on-demand, it was a fantast...

Read more

G42 and ONT Co-Develop Ultra-Scalable Solution for COVID-19 Detection (UAE)

9th June 2020

End-to-end solution will enable mass/on-demand screening to support the re-opening of global economies. Abu Dhabi; June 09, 2020: Group 42 (G42), a leading AI and Cloud Computing compan...

Read more

Blog: Ruminating on the rumen microbiome

9th June 2020

In this blog, Beatriz Delgado Corrales, Óscar González Recio, and Mónica Gutiérrez Rivas describe their work on classifying rumen microbiomes, comparing long-read and short-read sequencin...

Read more

Oxford Nanopore announces £48.4M ($59.2M) in new capital to support ongoing innovation and the rapid worldwide growth of nanopore sequencing

26th May 2020

26th May 2020, Oxford, UK: Oxford Nanopore Technologies has raised £48.4M ($59.2M) in new capital. The funding comes from new investors and existing shareholders in EMEA, US and Asia, a...

Read more

Oxford Nanopore Technologies announces advanced development of LamPORE, for rapid, highly scalable, low-cost COVID-19 detection

22nd May 2020

LamPORE is designed for use in both high-throughput labs or decentralised locations- Oxford Nanopore Technologies is in advanced development of a new generation of end-to-end test (assay...

Read more

96 barcodes: Expanded PCR-free multiplexing capacity for lower cost per sample – now available in store

21st May 2020

Latest kit release provides 96 native barcodes for PCR-free sequencing, allowing higher numbers of samples to be run on a single flow cell - including for SARS-CoV-2 whole genome sequenci...

Read more

Oxford Nanopore supports COVID-19 pandemic: epidemiology and research

21st May 2020

Please visit our updated COVID mini-site Oxford Nanopore is working with public health laboratories around the world, and researchers in related areas, to support the current COVID-19 pa...

Read more

MinION Mk1C now in-field, for COVID-19 and beyond

19th May 2020

From COVID-19 research and epidemiology to plant genomics, analysis of eDNA to whole genome sequencing, the applications of MinION Mk1C are now being thoroughly explored by the Nanopore C...

Read more

Interview: Nanopore sequencing: the missing puzzle piece in molecular identification

11th May 2020

Ahmed Abd El Wahed is a scientist at the Institute of Animal Hygiene, University of Leipzig, and established a mobile suitcase laboratory for the rapid detection of viruses, bacteria an...

Read more

Blog: PuntSeq - Portable nanopore sequencing of freshwater metagenomes

17th April 2020

In this blog, Lara Urban discusses the importance of freshwater microbial monitoring, and the founding of PuntSeq – a citizen science effort centred around using nanopore sequencing techn...

Read more

Blog: Metagenomic sequencing: which assembly method is best?

7th April 2020

In this blog, Adriel Latorre-Perez shares his work on comparing methods for assembling metagenomes from nanopore sequencing data, and he provides recommendations on the best tools to use ...

Read more

As China gets back to work, Novogene announces scaling of sequencing services on Oxford Nanopore PromethION

30th March 2020

As researchers from the broad scientific community in China are able to resume their research, Novogene, the global genome sequencing service provider, has announced that it will be scali...

Read more

UK creates COVID-19 genome sequencing alliance for large scale analysis of the virus; Oxford Nanopore sequencing technology supports rapid sequencing capabilities in the network

23rd March 2020

The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The network aims to sequenc...

Read more

Jury invalidates PacBio’s patents in U.S. patent trial against Oxford Nanopore

18th March 2020

After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences ("PacBio") in this lit...

Read more

New research algorithms yield accuracy gains for nanopore sequencing

6th March 2020

Latest basecalling algorithms from Oxford Nanopore’s Research & Development teams show consistent improvement to raw, consensus and variant calling accuracies, with latest tools and m...

Read more

NuProbe announces licensing deal with Oxford Nanopore, supporting highly sensitive variant analysis in cancer research

26th February 2020

Houston, US, Shanghai, China — NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, TX, has signed an agreement with Oxford Nanopore Technologies, ...

Read more

Blog: Long reads reveal small-scale structural variations in an allo-tetraploid crop plant

25th February 2020

Harmeet Singh Chawla, from Justus Liebig University Giessen, discusses how he developed a pipeline using long nanopore reads to investigate genomic structural variation in the major crop ...

Read more

ARTIC Network provides protocol for rapid, accurate sequencing of novel coronavirus (nCoV-2019): first genomes released

10th February 2020

When used with nanopore sequencing technology, the workflow can go from sample to genome within 8 hours On 5th February, the first nCoV-2019 genome was released, sequenced using methods ...

Read more
Open a chat to talk to our sales team